Abstract
A series of nicotinic acid hydrazides (1-19) was synthesized and tested in vitro for antimycobacterial, antiviral, antibacterial and antifungal activities. The antimycobacterial activity results indicated that the presence of electron withdrawing halo groups improved the antimycobacterial activity. The antiviral evaluation showed that none of the synthesized derivatives inhibited the replication of viruses at subtoxic concentrations, except compounds 9 and 12. The antimicrobial screening results demonstrated that compounds having methoxy and 2-hydroxy naphthalene substituents were the most active ones against tested microbial strains. QSAR investigations revealed that multi-target QSAR models were found to be more effective in describing the antimicrobial activity than one-target QSAR models.
Keywords: Nicotinic acid hydrazones, Synthesis, Antimycobacterial, Antiviral, QSAR, Tuberculosis, Mycobacterium tuberculosis, Human immunodeficiency virus (HIV), Hydrazone derivatives, cytotoxicity, Antimycobacterial Activity, Bacillus subtilis, minimum inhibitory concentrations (MIC)
Letters in Drug Design & Discovery
Title: Nicotinic Acid Benzylidene/Phenyl-Ethylidene Hydrazides: Synthesis, Antimicrobial Evaluation and QSAR Studies
Volume: 8 Issue: 8
Author(s): Rakesh Narang, Balasubramanian Narasimhan, Sunil Sharma, Dharmarajan Sriram, Perumal Yogeeswari, Erik De Clercq, Christophe Pannecouque and Jan Balzarini
Affiliation:
Keywords: Nicotinic acid hydrazones, Synthesis, Antimycobacterial, Antiviral, QSAR, Tuberculosis, Mycobacterium tuberculosis, Human immunodeficiency virus (HIV), Hydrazone derivatives, cytotoxicity, Antimycobacterial Activity, Bacillus subtilis, minimum inhibitory concentrations (MIC)
Abstract: A series of nicotinic acid hydrazides (1-19) was synthesized and tested in vitro for antimycobacterial, antiviral, antibacterial and antifungal activities. The antimycobacterial activity results indicated that the presence of electron withdrawing halo groups improved the antimycobacterial activity. The antiviral evaluation showed that none of the synthesized derivatives inhibited the replication of viruses at subtoxic concentrations, except compounds 9 and 12. The antimicrobial screening results demonstrated that compounds having methoxy and 2-hydroxy naphthalene substituents were the most active ones against tested microbial strains. QSAR investigations revealed that multi-target QSAR models were found to be more effective in describing the antimicrobial activity than one-target QSAR models.
Export Options
About this article
Cite this article as:
Narang Rakesh, Narasimhan Balasubramanian, Sharma Sunil, Sriram Dharmarajan, Yogeeswari Perumal, Clercq Erik De, Pannecouque Christophe and Balzarini Jan, Nicotinic Acid Benzylidene/Phenyl-Ethylidene Hydrazides: Synthesis, Antimicrobial Evaluation and QSAR Studies, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796575999
DOI https://dx.doi.org/10.2174/157018011796575999 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Differentially Enhancing Effects of Long-term Treatment with Serrazyme, Boswellia and Pine on Seminal Bacterial Detection in Patients with Chronic Bacterial or Inflammatory Prostatitis, Probably Related to Several Degrees of Bacterial Adherence
Current Clinical Pharmacology Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design Synthesis and Evaluation of Tetrazole-BasedHydrazone Derivatives Bearing a Pyridine Moiety as Antimicrobial Agents
Letters in Drug Design & Discovery Translational Multimodality Neuroimaging
Current Drug Targets Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy
Current Medicinal Chemistry WITHDRAWN: Current Trends in the Detection of Biological Proteins and Immunological Assays using Graphene Quantum Dots
Current Analytical Chemistry An Overview of Novel Coronavirus Disease 2019: A Global Havoc
Coronaviruses Machine Learning Techniques and Drug Design
Current Medicinal Chemistry Nitric Oxide and the Regulation of Apoptosis in Tumour Cells
Current Pharmaceutical Design Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis
Current Stem Cell Research & Therapy Preface [Hot topic: Carbohydrates (Executive Editor: Istvan Toth)]
Mini-Reviews in Medicinal Chemistry Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Current Genomics Drug Susceptibility Testing of <i>Mycobacterium Simiae</i>: An Emerging Pathogen in Iran
Infectious Disorders - Drug Targets Bioactive Peptides from Marine Sources as Potential Anti-Inflammatory Therapeutics
Current Protein & Peptide Science Essential Fatty Acids - A Review
Current Pharmaceutical Biotechnology Patent Selections
Recent Patents on Anti-Infective Drug Discovery Use of Genetically Modified Bacteria to Modulate Adaptive Immunity
Current Gene Therapy Noninvasive Assessment of Cytokines in Occupational Respiratory Diseases
Recent Patents on Inflammation & Allergy Drug Discovery On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials